Heart failure’s cost runs deep for patients, families and Canada’s healthcare system.
Does your team have up-to-date, evidence-based clinical standards in place to drive optimal outcomes for your patients?
Heart failure is a progressive disease. Mortality rates are high.
With each hospitalization, the risk of readmission rises and life expectancy decreases. Within 30 days of discharge, 21% of heart failure patients are readmitted for follow-up care.5
When structured into better tools and processes, this new knowledge can make a difference in treating heart failure and preventing hospital readmissions. But only if it makes it to the patient.
The Canadian Heart Failure Society (CHFS) has partnered with Think Research to update their standard heart failure Order Sets to align with up-to-date, evidence-based research.
Each time patients are admitted, they are back in the hospital 1 month faster than the last time.
Hospital Admissions: A Key Stage to Improve Heart Failure Outcomes
“There’s often a tendency to just say, ‘Let’s wait until we see the patient back in the clinic in a couple of weeks after hospital discharge.’ But the reality is that so often things are incredibly busy in the outpatient setting and many patients never get started on the right medications if we delay. Our message is to act now and help patients get the greatest benefits as early as possible.”
In this audio clip, Dr. Shelley Zieroth, President of the Canadian Heart Failure Society, describes how discharge coordination, an ongoing coordinated focus on outpatient care, and optimized, guideline-directed medical therapy can change the long-term trajectory for a patient’s heart failure journey.
Admissions are a critical stage in treating heart failure, and provide a unique opportunity to improve care for patients with this condition.
Strategies to reduce readmission rates include early patient discharge planning and scheduling follow-up appointments prior to discharge. Refer to the heart failure discharge checklist on the Order Set for a complete discharge bundle.
Patients should be provided with self-care tools before discharge. Detecting subtle changes in symptoms early is a key skill for heart failure patients to develop and integrate in their daily lives.
Daily diary use is a proven method to keep track of symptoms and recognize early signs of decompensation. Greater diary use is associated with better heart failure outcomes and longer survival rates.
CHFS has collaborated with patients to develop a Patient Diary to accompany them on their journey. We encourage healthcare professionals to download the document and provide it to their patients at discharge
Clinical trials involving guideline-directed medical therapies (GDMT) have been shown to improve patient outcomes and reduce costs to healthcare systems.
Inertia, however, is a known barrier to instituting evidence-based therapies. Clinicians and health systems have many priorities and commitments. The time required to update documentation and train clinical staff can easily become the positive intention that is months or years delayed.
Think Research’s Order Sets™ make it easy to keep your clinical protocols in line with the latest evidence-based recommendations. That’s why CHFS has partnered with Think Research to update their heart failure order set and make these new findings easily accessible.
Existing client partners within Think Research’s network may work with their in-house clinical and customer service teams to localize, implement and maintain the new CHFS Order Set.
You can still access the updated Order Set guideline. Think Research staff are available to answer any implementation questions you may have.
A digital event hosted by the Canadian Heart Failure Society
The Canadian Heart Failure Society’s (CHFS) mission is to improve patient care through research, advocacy, education and the development of best practices in the field of heart failure disorders.
Clinical Professor of Medicine, University of Calgary
Libin Cardiovascular Institute of Alberta, South Health Campus, Calgary
Past & Founding President, Canadian Heart Failure Society
Associate Professor, Cardiology, University of Manitoba
Director, SBH HF and Transplant Clinics
Head, Medical HF Program, WRHA Cardiac Sciences
President, Canadian Heart Failure Society
Medical Co-Director, Heart Function and Rapid Cardiology Assessment Clinic
Cardiologist, Sunnybrook Health Sciences Centre
Assistant Professor, University of Toronto
1, 2) 2017 Heart disease in Canada: Highlights from the Canadian Chronic Disease Surveillance System.
3) A snapshot of Health in Canada as Demonstrated by Top 10 Lists. Canadian institute for Health Information. Hospital Stays in Canada (2017–18).
4) Canadian institute for Health Information. Hospital Stays in Canada (2017–18).
5) O’Connor, Christopher M. “High Heart Failure Readmission Rates: Is it the Health System’s Fault?” JACC: Heart Failure, May 2017
6) Bakal, Jeffrey A., et al. “Heart Failure Re-Admission: Measuring the Ever Shortening Gap between Repeat Heart Failure Hospitalizations.” PLoS ONE, vol. 9, no. 9, 2014, doi:10.1371/journal.pone.0106494.
7) Ivabradine use more consistent in HF patients with in-hospital recommendation
This content was exclusively developed by the Canadian Heart Failure Society, a not-for-profit medical society that receives support from commercial partners to support their educational activities. For more information click here.